Vanda Pharmaceuticals’ Imsidolimab BLA Accepted by FDA for Generalized Pustular Psoriasis Treatment
Vanda Pharmaceuticals has received FDA acceptance for its Biologics License Application (BLA) seeking approval of imsidolimab as a treatment for…
Vanda Pharmaceuticals has received FDA acceptance for its Biologics License Application (BLA) seeking approval of imsidolimab as a treatment for…